Startseite>>Signaling Pathways>> DNA Damage/DNA Repair>>4-oxo-27-TBDMS Withaferin A

4-oxo-27-TBDMS Withaferin A

Katalog-Nr.GC45353

4-oxo-27-TBDMS Withaferin A, ein Withaferin A-Derivat, zeigt starke antiproliferative Wirkungen auf die Tumorzellen. 4-oxo-27-TBDMS Withaferin A induziert die Apoptose von Tumorzellen. 4-Oxo-27-TBDMS Withaferin A ist ein Antikrebsmittel.

Products are for research use only. Not for human use. We do not sell to patients.

4-oxo-27-TBDMS Withaferin A Chemische Struktur

Cas No.: 1214886-31-3

Größe Preis Lagerbestand Menge
1mg
111,00 $
Auf Lager
5mg
335,00 $
Auf Lager
10mg
556,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

4-oxo-27-TBDMS Withaferin A is a derivative of the steroidal lactone withaferin A that has anticancer activity.1 It is cytotoxic to A2780 ovarian cancer cells (IC50 = 17 μM) but not to carboplatin-resistant A2780 (A2780/CP70) cells (IC50 = >100 μM). It is selective for A2780 cells over non-cancerous ARPE19 cells (IC50 = 1,660 μM). 4-oxo-27-TBDMS Withaferin A induces DNA fragmentation in A2780 cells.

References
1. Perestelo, N.R., Llanos, G.G., Reyes, C.P., et al. Expanding the chemical space of withaferin A by incorporating silicon to improve its clinical potential on human ovarian carcinoma cells. J. Med. Chem. 62(9), 4571-4585 (2019).

Bewertungen

Review for 4-oxo-27-TBDMS Withaferin A

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4-oxo-27-TBDMS Withaferin A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.